Clinical Trial

Noninvasive Thalamocortical Neuromodulation With Low-Intensity Focused Ultrasound for Persistent Developmental Stuttering

Recruiting
View on ClinicalTrials.gov →
Summary
This research is studying the use of low-intensity focused ultrasound (LIFU; a mild, noninvasive acoustic stimulation technique) in a small number of people to learn about its safety as a treatment for stuttering. LIFU is a small, safe sound signal that produces a gentle, pulsing flow of acoustic waves to help different parts of the brain communicate with each other. Researchers want to understand how the mild, non-invasive brain stimulation affects speech relevant brain areas, which may in turn affect speech fluency and speaking-related brain activity in people who stutter.
Protocol Amendment History 5 changes
critical Recruitment opened 2026-08-13
notable Primary completion pushed: 2027-07 -> 2027-08 2026-08-13
minor Completion pushed: 2027-07 -> 2027-08 2026-08-13
notable Primary completion pushed: 2027-06 -> 2027-07 2026-07-24
minor Completion pushed: 2027-06 -> 2027-07 2026-07-24
Trial Details
NCT Number NCT07668882
Lead Sponsor University of Michigan
Collaborators: Michigan Pioneer Fellowship
Conditions Stuttering, Developmental Stuttering
Enrollment 20 participants
Start Date 2026-08
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-12